CHEMOCENTRYX INC - COMMON STOCK (CCXI) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2025

Type / Class
Equity / COMMON STOCK
Symbol
CCXI
Price per share
$52.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1
Total reported value
$52
Share change
0
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 1 institutional investors reported holding 1 shares of CHEMOCENTRYX INC - COMMON STOCK (CCXI).

Institutional Holders of CHEMOCENTRYX INC - COMMON STOCK (CCXI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 1 $52 $52.00 1
2025 Q2 1 $52 $52.00 1
2025 Q1 1 $52 $52.00 1
2024 Q4 1 $52 $52.00 1
2024 Q3 1 $52 $52.00 1
2024 Q2 1 $52 $52.00 1
2024 Q1 1 $52 $52.00 1
2023 Q4 1 $52 $52.00 1
2023 Q3 1 $52 $52.00 1
2023 Q2 1 $52 $52.00 1
2023 Q1 1 $52 $52.00 1
2022 Q4 1 $52 -$3,190,002,088 $52.00 1
2022 Q3 61,866,034 $3,195,989,505 +$503,721,161 $51.66 211
2022 Q2 58,140,310 $1,440,735,628 +$66,695,051 $24.78 175
2022 Q1 55,794,985 $1,398,362,447 +$43,502,635 $25.07 166
2021 Q4 52,864,033 $1,924,725,126 +$355,353,478 $36.41 182
2021 Q3 44,056,395 $754,423,237 -$3,847,663 $17.10 134
2021 Q2 44,665,564 $598,360,275 -$815,091,790 $13.39 135
2021 Q1 55,119,806 $2,823,948,407 -$102,195,673 $51.24 177
2020 Q4 56,377,748 $3,490,840,337 +$32,906,744 $61.92 191
2020 Q3 55,863,122 $3,060,688,837 +$156,640,518 $54.80 196
2020 Q2 52,817,515 $3,038,286,407 +$551,888,761 $57.54 185
2020 Q1 44,030,097 $1,769,068,350 +$176,799,459 $40.18 157
2019 Q4 39,657,817 $1,567,773,073 +$230,086,062 $39.55 124
2019 Q3 35,221,357 $238,788,865 -$19,437,110 $6.78 97
2019 Q2 37,181,564 $345,703,987 +$30,070,854 $9.30 112
2019 Q1 33,750,165 $468,681,057 +$91,798,902 $13.89 116
2018 Q4 27,342,477 $298,366,155 +$1,002,174 $10.91 107
2018 Q3 27,212,286 $343,564,178 +$3,741,745 $12.64 106
2018 Q2 26,837,737 $353,630,201 +$28,603,232 $13.17 114
2018 Q1 24,637,337 $335,075,755 +$19,568,488 $13.60 99
2017 Q4 23,681,570 $140,895,125 -$1,326,707 $5.95 86
2017 Q3 23,848,981 $176,983,921 -$5,240,132 $7.42 86
2017 Q2 24,414,877 $228,524,497 +$6,355,863 $9.36 86
2017 Q1 23,780,256 $173,115,299 +$17,892,864 $7.28 82
2016 Q4 23,426,717 $173,318,406 +$4,639,189 $7.40 89
2016 Q3 22,676,491 $136,956,696 +$706,997 $6.04 71
2016 Q2 22,829,359 $102,499,927 -$443,381 $4.49 76
2016 Q1 24,919,943 $61,666,000 -$11,769,830 $2.49 69
2015 Q4 25,053,110 $202,925,522 -$14,568,156 $8.10 70
2015 Q3 26,933,764 $162,943,519 +$3,828,915 $6.05 64
2015 Q2 26,281,258 $216,290,065 -$1,600,579 $8.23 70
2015 Q1 26,538,125 $200,436,767 -$261,690 $7.55 68
2014 Q4 26,703,415 $182,280,469 -$529,372 $6.83 64
2014 Q3 27,292,460 $122,806,183 +$3,200,021 $4.50 63
2014 Q2 26,534,686 $155,210,674 -$993,606 $5.85 63
2014 Q1 26,629,752 $176,524,871 +$19,996,310 $6.63 64